REG - JP Morgan Sec LLC Aon PLC - AON plc 8.3

AonAnnouncement

05/02/2021 14:41

RNS Number : 2054O
  
J.P. Morgan Securities LLC
  
05 February 2021
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


J.P. Morgan Securities LLC




Company dealt in


AON plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.01 ordinary shares




Date of dealing


 04 February 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


7,295,679                3.19


2,709,949             1.20




(2) Derivatives (other than options)


2,449,617                1.09


24,832                0.01




(3) Options and agreements to purchase/sell


 


 




Total


9,745,296             4.28


2,734,781             1.21



 
 
 
 
 
 
 



 

 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
        Purchase/sale


 
Number of relevant securities


 
Price per unit (USD)
 
 (Note 5)




Sale (Borrow return)
 
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
 
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales


72,100
 
11 
 3 
 100 
 91 
 246 
 45 
 3 
 1,500 
 1 
 50 
 2 
 2 
 8 
 7 
 40 
 9 
 2 
 3 
 8 
 264 
 108 
 8 
 2,810 
 361 
 100 
 390 
 322 
 157 
 80 
 44 
 44 
 100 
 509 
 40 
 2,375 
 5,277 
 5,277 
 
 100 
 11 
 25 
 100 
 74 
 17 
 40 
 381 
 246 
 2 
 50 
 600 
 1 
 2 
 1,500 
 709 
 17 
 20 
 5 
 2 
 100 
 22 
 4 
 19 
 8 
 11 
 10 
 2 
 3 
 7,680 
 1 
 5,277 
 5,277


N/A
 
205.2700     USD
205.4400     USD
205.6700     USD
205.6850     USD
205.7905     USD
206.1007     USD
206.2300     USD
206.3911     USD
206.8100     USD
206.9900     USD
207.0200     USD
207.0500     USD
207.1400     USD
207.1500     USD
207.1700     USD
207.2022     USD
207.2800     USD
207.2900     USD
207.3100     USD
207.3130     USD
207.3500     USD
207.5000     USD
207.5481     USD
207.5551     USD
207.5800     USD
207.5814     USD
207.5815     USD
207.6171     USD
207.6300     USD
207.6400     USD
207.6500     USD
207.8300     USD
207.9427     USD
208.0600     USD
208.1000     USD
208.5295     USD
208.5420     USD
                        
204.8600     USD
205.2700     USD
205.3873     USD
205.4400     USD
205.5957     USD
205.6500     USD
205.7200     USD
205.7615     USD
205.7905     USD
206.2900     USD
206.3300     USD
206.3483     USD
206.3500     USD
206.3900     USD
206.3911     USD
206.5302     USD
206.5918     USD
206.6100     USD
206.8640     USD
206.9900     USD
207.0100     USD
207.0186     USD
207.1150     USD
207.1853     USD
207.2450     USD
207.4591     USD
207.4920     USD
208.0300     USD
208.0600     USD
208.1000     USD
208.1100     USD
208.5295     USD
208.5420     USD



 
 
 
 



 
 
 
 
 
 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(USD)
(Note 5)




Equity Swap


Long
Long
 
Short


400 
 1,100 
 
5,277


206.1550     USD
206.4770     USD
                        
208.5420     USD




 
 
 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price (USD)


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant 

securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 
      None
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            No
 




Date of disclosure


 05 February 2021




Contact name


Alwyn Basch




Telephone number


0207 742 7407




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISETAMITMTJMBAB